uk nsc stakeholder event 2017 dr louise bryant presentation

27
Public Health England leads the NHS Screening Programmes Facilitating informed choices in screening Dr Louise Bryant, Associate Professor in Medical Psychology, University of Leeds

Upload: phescreening

Post on 22-Jan-2018

384 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Public Health England leads the NHS Screening Programmes

Facilitating informed choices in

screening

Dr Louise Bryant, Associate

Professor in Medical Psychology,

University of Leeds

Page 2: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

UK NSC four country definition: personalised

informed choice

2 Facilitating informed choices in screening

the condition being

screened for

the testing process

benefits and harms

potential outcomes

“A personal decision made to accept or decline a screening test based on

access to accurate, evidence-based information covering……..”

“There should also be the opportunity to reflect on what the test and its

results might mean to the individual”

Page 3: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Personalised informed choice: context

3 Facilitating informed choices in screening

Alternative views exist on the value of

screening tests

Ability to use health

information to make decisions

is limited

The screening environment

matters

Page 4: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

“.. all the doctors not knowing

if it is malignant or not, you

add them all together and you

think, ‘Why bother?’1

4 Facilitating informed choices in screening

“Screening

mammograms

are next to

worthless”2

Alternative views on screening

“I just want [my doctor] to say,

‘You should go, you must go ...

this is where you go.’” 1

Page 5: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Unhappiness with ‘informed choice’

5 Facilitating informed choices in screening

“While you have .. targets on

screening uptake you cannot

truly claim to be giving people

choice…you have already

decided the ‘right’ decision” 3

“I'm sure the authorities look at

the figures of how many women

screened and think we adore the

programme where in reality we

are harassed and coerced into

complying”

(on cervical screening)3

Page 7: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

7 Facilitating informed choices in screening

“The condition should be an

important health problem as

judged by its frequency

and/or severity”

Page 8: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

8 Facilitating informed choices in screening

“There should be an

effective intervention”

Page 9: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Information development by ‘user need’

As a person being offered a screening test

I need to understand the benefits and harms of

having the test

So that I can decide whether it is right for me to

have the test or not

9 Facilitating informed choices in screening

Page 10: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

10 Facilitating informed choices in screening

Ability to use health information to make

decisions

Page 11: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Ability to use health information to make

decisions

11 Facilitating informed choices in screening

“Between 43% and 61% of English working age

adults routinely do not understand health

information”

Jonathan Berry, NHS England

Page 12: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Health literacy, numeracy and graphicacy

12 Facilitating informed choices in screening

The capacity to obtain, understand and act on….

Basic health information and

services e.g. leaflets

Numerical health information

e.g. probability

Health information in non-textual 2D

formats e.g. graphs and diagrams

DECISION

Page 13: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

13 Facilitating informed choices in screening

Page 14: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

14 Facilitating informed choices in screening

Page 15: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

15 Facilitating informed choices in screening

Page 16: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

16 Facilitating informed choices in screening

Page 17: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Understanding harms to the individual

Further invasive procedures, e.g.

colonoscopy

Over

treatment

Psychological

impacts

Anxiety

17 Facilitating informed choices in screening

Page 18: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Difficult decisions

“It’s a **** decision”

18 Facilitating informed choices in screening

Page 19: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

The screening environment

19 Facilitating informed choices in screening

Page 20: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

20 Facilitating informed choices in screening

“The enduring human fear of

what the future holds means

that it is never easy to

decline the promised

benefits of screening.

Such refusal seems to tempt

fate in a disturbingly primeval

way”

Iona Heath, GP, 2009 BMJ4

Page 21: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Time pressure

21 Facilitating informed choices in screening

Page 22: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

22 Facilitating informed choices in screening

“Due to the implementation process

a decision is required immediately…

therefore if there is some indecision

it is more common to recommend

screening and decline later”

(Midwife)5

Page 23: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Technology

23 Facilitating informed choices in screening

Page 24: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Social context of NIPT

24 Facilitating informed choices in screening

“Nearly 100%

accurate”“100% safe”

“Earlier, safe, more accurate”

“Midwife

says never

seen one

not

confirmed”

“NHS test

pointless”

“Uses the

baby’s DNA”

Over 99%

accurate for

Down’s

syndrome“worth every

penny”

Page 25: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Where we started…

25 Facilitating informed choices in screening

the condition being

screened for

the testing process

benefits and harms

potential outcomes

“A personal decision made to accept or decline a screening test based on

access to accurate, evidence-based information covering……..”

“There should also be the opportunity to reflect on what the test and its

results might mean to the individual”

Page 26: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

Key points...

Alternative views exist on the value of screening

tests

Ability to use health

information to make

decisions is limited

The context of the screening offer matters

Informed choice is a complex

process - not an outcome

26 Facilitating informed choices in screening

Page 27: UK NSC stakeholder event 2017 Dr Louise Bryant presentation

References1 Hersch, Jolyn, et al. "Women’s views on over diagnosis in breast cancer

screening: a qualitative study." Bmj 346 (2013): f158.

2 https://www.canceractive.com/cancer-active-page-link.aspx?n=1420

3 How do we help people decide if screening is the right choice for them? Anne

Mackie, Posted on: 3 August 2015

4 Heath, Iona. "It is not wrong to say no." BMJ: British Medical Journal (Online)

338 (2009)

5 Ukuhor, Hyacinth O., et al. "A Framework for Describing the Influence of

Service Organisation and Delivery on Participation in Fetal Anomaly

Screening in England." Journal of pregnancy 2017

27 Facilitating informed choices in screening